SCICLONE PHARMACEUTICALS INC 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Mar 9, 2017
Insider Transaction Report
Form 4
Low Raymond Anthony
VP, Finance & Controller
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2017-03-08+24,426→ 24,426 totalExercise: $9.65Exp: 2027-03-08→ Common Stock (24,426 underlying) - Award
Restricted Stock Unit
2017-03-08+5,000→ 23,750 totalExp: 2027-03-08→ Common Stock (5,000 underlying) - Award
Incentive Stock Option (right to buy)
2017-03-08+10,574→ 10,574 totalExercise: $9.65Exp: 2027-03-08→ Common Stock (10,574 underlying)
Footnotes (4)
- [F1]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F3]Vesting for such RSUs will occur 25% on March 8, 2018, 25% on March 8, 2019, 25% on March 8, 2020, and 25% on March 8, 2021, contingent upon the executive's continued employment.
- [F4]25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.